Trial Parameters
Brief Summary
If steroid diabetes is not recognized in time, it will cause irreversible damage to the body. Nephropathy patients are more likely to have steroid diabetes ,the incidence rate up to 25%,due to hypoalbuminemia, high-dose hormone and other reasons, so they need to be closely followed up, identified and intervened in time.
Eligibility Criteria
Inclusion Criteria: 1. Patients who need to use glucocorticoids due to the following diseases: nephrotic syndrome, Immunoglobulin A nephropathy, membranous nephropathy, Anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV), systemic lupus erythematosus； 2. Initial daily dose of glucocorticoids greater than or equal to 10mg of prednisolone； Exclusion Criteria: 1. Patients with diabetes； 2. Those who are unable to communicate through language； 3. Uremic patients； 4. Unable to perform blood glucose monitoring and follow-up as required； 5. Those who have used glucocorticoids within the past 3 months and have accumulated a dose of 10mg or more of prednisone； 6. Participated in other clinical studies。